HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms von Yue, Lanzhu, Sharma, Vasundhara, Horvat, Nathan P., Akuffo, Afua A., Beatty, Matthew S., Murdun, Cem, Colin, Christelle, Billington, Julia M.R., Goodheart, William E., Sahakian, Eva, Zhang, Ling, Powers, John J., Amin, Narmin E., Lambert-Showers, Que T., Darville, Lancia N., Pinilla-Ibarz, Javier, Reuther, Gary W., Wright, Kenneth L., Conti, Chiara, Lee, Jennifer Y., Zheng, Xiaozhang, Ng, Pui Yee, Martin, Matthew W., Marshall, C. Gary, Koomen, John M., Levine, Ross L., Verma, Amit, Grimes, H. Leighton, Sotomayor, Eduardo M., Shao, Zonghong, Epling-Burnette, Pearlie K.

Volltext

The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN von Mazzacurati, Lucia, Collins, Robert J., Pandey, Garima, Lambert-Showers, Que T., Amin, Narmin E., Zhang, Ling, Stubbs, Matthew C., Epling-Burnette, Pearlie K., Koblish, Holly K., Reuther, Gary W.

Volltext

SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms von Pandey, Garima, Mazzacurati, Lucia, Rowsell, Tegan M., Horvat, Nathan P., Amin, Narmin E., Zhang, Guolin, Akuffo, Afua A., Colin‐Leitzinger, Christelle M., Haura, Eric B., Kuykendall, Andrew T., Zhang, Ling, Epling‐Burnette, Pearlie K., Reuther, Gary W.

Volltext

Porphyrin overdrive rewires cancer cell metabolism von Adapa, Swamy R, Hunter, Gregory A, Amin, Narmin E, Marinescu, Christopher, Borsky, Andrew, Sagatys, Elizabeth M, Sebti, Said M, Reuther, Gary W, Ferreira, Gloria C, Jiang, Rays Hy

Volltext

SHP2 Inhibition Suppresses RAS-ERK Signaling, the Development of JAK2 Inhibitor Persistence, and MPN Development in Pre-Clinical Models of Myeloproliferative Neoplasms von Pandey, Garima, Horvat, Nathan, Amin, Narmin E., Zhang, Guolin, Mazzacurati, Lucia, Akuffo, Afua A., Colin-Leitzinger, Christelle, Haura, Eric B., Epling-Burnette, Pearlie K., Reuther, Gary W.

Volltext

SHP2 Inhibition Enhances JAK2 Inhibitor Therapy in Preclinical Models of Myeloproliferative Neoplasms von Pandey, Garima, Mazzacurati, Lucia, Horvat, Nathan P., Rowsell, Tegan, Amin, Narmin E., Zhang, Guolin, Akuffo, Afua Adutwumwa, Colin-Leitzinger, Christelle M., Haura, Eric B., Kuykendall, Andrew T., Epling-Burnette, PK, Reuther, Gary W.

Volltext

RMC-4550, an Allosteric Inhibitor of SHP2, Displays Therapeutic Efficacy in Pre-Clinical Models of Myeloproliferative Neoplasms von Pandey, Garima, Horvat, Nathan, Amin, Narmin E., Akuffo, Afua A., Colin, Christelle, Epling-Burnette, Pearlie K., Reuther, Gary W.

Volltext

Correction: Porphyrin overdrive rewires cancer cell metabolism von Adapa, Swamy R, Hunter, Gregory A, Amin, Narmin E, Marinescu, Christopher, Borsky, Andrew, Sagatys, Elizabeth M, Sebti, Said M, Reuther, Gary W, Ferreira, Gloria C, Jiang, Rays Hy

Volltext

Selective Targeting of Histone Deacetylase 11 Disables Metabolism of Myeloproliferative Neoplasms von Sharma, Vasundhara, Yue, Lanzhu, Horvat, Nathan P., Christodoulidou, Agni, Akuffo, Afua Adutwumwa, Beatty, Mathew, Murdun, Cem, Billington, Julia, Goodheart, William E, Sahakian, Eva, Zhang, Ling, Powers, John J., Amin, Narmin E., Lambert-Showers, Que T., Darville, Lancia, Pinilla Ibarz, Javier, Reuther, Gary W., Lee, Jennifer, Zheng, Xiaozhang, Yee Ng, Pui, Martin, Mathew W., Marshall, Gary C., Koomen, John M., Levine, Ross L., Verma, Amit, Grimes, H. Leighton, Sotomayor, Eduardo, Shao, Zonghong, Wright, Kenneth, Epling-Burnette, Pearlie K.

Volltext